mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for KIF2C
Gene summary
Basic gene Info.Gene symbolKIF2C
Gene namekinesin family member 2C
SynonymsCT139|KNSL6|MCAK
CytomapUCSC genome browser: 1p34.1
Type of geneprotein-coding
RefGenesNM_001297655.1,
NM_001297656.1,NM_001297657.1,NM_006845.3,
Descriptionkinesin-like protein 6kinesin-like protein KIF2Cmitotic centromere-associated kinesin
Modification date20141207
dbXrefs MIM : 604538
HGNC : HGNC
Ensembl : ENSG00000142945
HPRD : 05172
Vega : OTTHUMG00000008416
ProteinUniProt: Q99661
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_KIF2C
BioGPS: 11004
PathwayNCI Pathway Interaction Database: KIF2C
KEGG: KIF2C
REACTOME: KIF2C
Pathway Commons: KIF2C
ContextiHOP: KIF2C
ligand binding site mutation search in PubMed: KIF2C
UCL Cancer Institute: KIF2C
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0007019microtubule depolymerization21820309


Top
Ligand binding site mutations for KIF2C
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
D312D312HHNSC1
S468S470FSKCM1
R266R266CUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for KIF2C
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R266R266C-0.9084867
D312D312H-0.73268644
S468S470F-0.58546875
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for KIF2C from PDB

Top
Differential gene expression and gene-gene network for KIF2C
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of KIF2C and the right PPI network was created from samples without mutations in the LBS of KIF2C. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for KIF2C
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for KIF2C
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
ExperimentalDB04395Phosphoaminophosphonic Acid-Adenylate EsterSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of KIF2C go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
IIIPeptide ligand (LEU,GLU,GLU,GLN,ALA,SER,ARG)4ubfBD312
ADPADP2hehAR266
ADPADP4ubfBR266
ADPADP4ubfCR266
ADPADP4ubfDR266
ADPADP4y05AR266
MGMAGNESIUM(2+)4ubfDS468


Top
Conservation information for LBS of KIF2C
Multiple alignments for Q99661 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas